Strides Shasun gets tentative USFDA nod for Roflumilast tablets
NEW DELHI: Strides Shasun has received tentative approval from the US health regulator for Roflumilast tablets, used for the treatment of inflammatory conditions of the lungs. The company has received tentative approval from the US Food and Drug Administration (USFDA) for Roflumilast tablets 500 mcg, Strides Shasun said in a BSE filing…